Short-course radiotherapy and chemotherapy for conversion surgery in patients with unresectable metastatic rectal cancer:a preliminary case series study

다국어 초록 (Multilingual Abstract)

Purpose: Curative treatment is challenging in patients with locally advanced rectal cancer and unresectable metastases. The aim of this study was to evaluate the clinical outcomes of short-course radiotherapy (RT) followed by systemic chemotherapy for patients with rectal cancer with mesorectal fascia (MRF) involvement and unresectable distant metastases.
Methods: The study included consecutive patients diagnosed as having metastatic mid-to-low rectal cancer treated with short-course RT followed by systemic chemotherapy for conversion radical or palliative surgery between 2014 and 2019 at Gil Medical Center. The patients had primary rectal tumors involving the MRF and unresectable distant metastases. The treatment strategies were determined in a multidisciplinary team discussion.
Results: Seven patients (five men and two women) underwent short-course RT (5×5 Gy) and preoperative systemic chemotherapy. The median age was 68 years (range, 46–84 years), and the median distance from the anal verge to the primary tumor was 6.0 cm (range, 2.0–9.0 cm). During the median follow-up period of 29.4 months, three patients underwent conversion radical surgery with R0 resection, two underwent palliative surgery, and two could not undergo surgery. No postoperative major morbidity or mortality occurred. The patients who underwent conversion complete radical surgery showed good long-term survival outcomes, with an overall survival time of 29.4–48.8 months and progression-free survival time of 14.7–41.1 months.
Conclusion: Short-course RT followed by systemic chemotherapy could provide patients with unresectable stage IV rectal cancer a chance to undergo to conversion radical surgery with good long-term survival outcomes.

참고문헌 (Reference)

1 Shin SJ, "Upfront systemic chemotherapy and preoperative short-course radiotherapy with delayed surgery for locally advanced rectal cancer with distant metastases" 6 : 99-, 2011

2 Park JH, "The beneficial effect of palliative resection in metastatic colorectal cancer" 108 : 1425-1431, 2013

3 Ito K, "Surgical treatment of hepatic colorectal metastasis : evolving role in the setting of improving systemic therapies and ablative treatments in the 21st century" 16 : 103-110, 2010

4 Gulack BC, "Surgical resection of the primary tumor in stage IV colorectal cancer without metastasectomy is associated with improved overall survival compared with chemotherapy/radiation therapy alone" 59 : 299-305, 2016

5 Bisschop C, "Short-course radiotherapy followed by neoadjuvant bevacizumab, capecitabine, and oxaliplatin and subsequent radical treatment in primary stage IV rectal cancer : long-term results of a phase II study" 24 : 2632-2638, 2017

6 Adam R, "Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy : a model to predict long-term survival" 240 : 644-657, 2004

7 Glynne-Jones R, "Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up" 28 (28): iv22-iv40, 2017

8 Braendengen M, "Randomized phase III study comparing preoperative radiotherapy with chemoradiotherapy in nonresectable rectal cancer" 26 : 3687-3694, 2008

9 Shida D, "Prognostic impact of palliative primary tumor resection for unresectable stage 4 colorectal cancer : using a propensity score analysis" 23 : 3602-3608, 2016

10 Sauer R, "Preoperative versus postoperative chemoradiotherapy for rectal cancer" 351 : 1731-1740, 2004

11 Ceelen WP, "Preoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancer" (1) : CD006041-, 2009

12 Costi R, "Palliative resection of colorectal cancer: does it prolong survival?" 14 : 2567-2576, 2007

13 Devaud N, "Liver resection after chemotherapy and tumour downsizing in patients with initially unresectable colorectal cancer liver metastases" 16 : 475-480, 2014

14 Lemmens VE, "Improvements in population-based survival of patients presenting with metastatic rectal cancer in the south of the Netherlands, 1992-2008" 28 : 283-290, 2011

15 Heinemann V, "FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer(FIRE-3) : a randomised, open-label, phase 3 trial" 15 : 1065-1075, 2014

16 van Dijk TH, "Evaluation of short-course radiotherapy followed by neoadjuvant bevacizumab, capecitabine, and oxaliplatin and subsequent radical surgical treatment in primary stage IV rectal cancer" 24 : 1762-1769, 2013

17 Meta-analysis Group In Cancer, "Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer" 16 : 301-308, 1998

18 Nozawa H, "Conversion to resection in patients receiving systemic chemotherapy for unresectable and/or metastatic colorectal cancer-predictive factors and prognosis" 17 : e91-e97, 2018

19 Kabbinavar FF, "Combined analysis of efficacy : the addition of bevacizumab to fluorouracil/leucovorin improves survival for patients with metastatic colorectal cancer" 23 : 3706-3712, 2005

20 Hofheinz RD, "Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer : a randomised, multicentre, non-inferiority, phase 3 trial" 13 : 579-588, 2012

21 Van Cutsem E, "Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer : updated analysis of overall survival according to tumor KRAS and BRAF mutation status" 29 : 2011-2019, 2011

22 Maroney S, "Benefit of surgical resection of the primary tumor in patients undergoing chemotherapy for stage IV colorectal cancer with unresected metastasis" 22 : 460-466, 2018

23 Lee SH, "Aggressive surgical resection for concomitant liver and lung metastasis in colorectal cancer" 20 : 110-115, 2016

24 Lam VW, "A systematic review of clinical response and survival outcomes of downsizing systemic chemotherapy and rescue liver surgery in patients with initially unresectable colorectal liver metastases" 19 : 1292-1301, 2012

25 Leporrier J, "A population-based study of the incidence, management and prognosis of hepatic metastases from colorectal cancer" 93 : 465-474, 2006